SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-18-005487
Filing Date
2018-03-13
Accepted
2018-03-13 17:07:58
Documents
4
Effectiveness Date
2018-03-13

Document Format Files

Seq Description Document Type Size
1 2018 S-8 snss-s8.htm S-8 214411
2 EX-5.1 snss-ex51_7.htm EX-5.1 10691
3 EX-23.1 snss-ex231_6.htm EX-23.1 2839
4 GRAPHIC g201803131803464045320.jpg GRAPHIC 2548
  Complete submission text file 0001564590-18-005487.txt   232768
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-223632 | Film No.: 18687280
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1